Titlebook: Cannabinoids and Pain; Samer N. Narouze Book 2021 Springer Nature Switzerland AG 2021 Cannabis.Medical Marijuana.Cannabinoids.Endocannabin

Exposure

加強防衛(wèi)

Asperity

Cannabis Regulationsucts (cannabinoids) for specific medicinal purposes. This chapter aims to provide physicians and other healthcare providers with an up-to-date understanding of the current legal framework surrounding medical cannabis.

meretricious

調(diào)整

Cannabis Terminologycommendations for medical cannabis applications. Starting from the general aspects of the cannabis plant, this chapter described its main characteristics and the terminology used to describe various elements. Such fundamental understanding is essential to support future learning of the clinical application of cannabinoid-based medicines.

發(fā)怨言

Endocannabinoids: Anandamide and 2-Arachidonoylglycerol (2-AG)d chemotherapy-induced pain. 2-AG has a higher concentration in the nervous tissue and may have a greater role in analgesia and antinociception when compared to anandamide. The endocannabinoid signaling system involving 2-AG and anandamide includes a differential but synergistic role when looking at pharmacological properties.

閃光東本

Iatrogenic

Cannabinoid Receptor 1 (CB1) of neurotransmitters. Once activated, CB1 receptors undergo inactivation and internalization. CB1 receptors are located throughout the central nervous system with reported low density in the medullary nucleus.

負擔

.Offers strategies on when to recommend medical cannabis and.This book presents a well-balanced view of the potential medical use of cannabinoids in pain. It comprehensively covers the current challenges with medical cannabis utilization and provides recommendations for research and future direction

托人看管